Related Experiment Video
Updated: Aug 30, 2026

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice
Published on: October 25, 2024
Drugs and probes: the symbiotic relationship between pharmaceutical discovery and imaging science
Derek Maclean1, Jeffrey P Northrop, Henry C Padgett
1PETNET Pharmaceuticals, L.A. Technology Center, Culver City, CA 90230, USA. maclean@netcom.com
Abstract:
Pharmaceutical research and imaging science are becoming increasingly intertwined. Positron emission tomography (PET) is a molecular imaging technique with particularly broad application in drug discovery and development. At the same time, modern techniques of drug discovery are helping accelerate the development of new PET probes. This article describes the relationship between the two fields, with particular consideration of practical and strategic limitations to full utilization of available technology.
More Related Videos
07:05Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
Published on: June 20, 2025
10:16Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
Related Concept Videos
Drug Discovery: Overview
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
X-ray Diffraction of Biological Samples
According to Bragg's law, when X-rays strike the sample positioned on a stage, the rays are scattered by the electron clouds around the sample atoms. The X-ray diffraction or scattering is caused by constructive interference of the X-ray waves that reflect off the internal crystal...
Pharmacogenomics: Identification of New Drug Targets
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...